X T L Biopharmaceuticals reported $1.34M in Current Assets for its fiscal quarter ending in December of 2024.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
X T L Biopharmaceuticals USD 1.34M 647K Dec/2024